HIGHLIGHTS
- who: Daniela Giuliani from the Department of Biomedical, Metabolic and Neural Sciences, Section of Pharmacology and Molecular Medicine, University of Modena and Reggio Emilia, Modena, Italy have published the paper: Multiple beneficial effects of melanocortin MC4 receptor agonists in experimental neurodegenerative disorders: Therapeutic perspectives, in the Journal: (JOURNAL)
- what: The authors review the protective actions of melanocortins in the experimental neurodegenerative conditions thus far investigated, including mechanisms of action, and discuss the possibility to extend the use of melanocortin agonists for treatment of other neurodegenerative disorders.
- how: Showed that pretreatment with selective melanocortin . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.